Suvorexant in Insomnia Co-morbid With Fibromyalgia

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Insomnia, Fibromyalgia

In brief

This study will compare sleep, pain and daytime sleepiness/fatigue in people with insomnia co-morbid with fibromyalgia while treated short-term with suvorexant 20 mg versus placebo.

Key facts

Study ID

NCT02684136

Run by

Henry Ford Health System

People needed

10

Starts

2016-02-01

Expected to finish

2018-07-01

Last updated by the study team

2021-06-16

Who can join

Age: 21 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• meet Diagnostic and Statistical Manual 5th ed criteria for insomnia
• meet American College of Rheumatology criteria for fibromyalgia
• otherwise good psychiatric and stable physical health

You may not qualify if…

• other primary sleep disorders
• pain symptoms unrelated to fibromyalgia
• current pregnancy or breast-feeding

Where it is running

• HFHS Sleep Disorders Ctr — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.